Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 1—January 2016
Research

Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia

Abdullah M. Assiri, Glen R. AbediComments to Author , Abdulaziz A. Bin Saeed, Mutwakil A. Abdalla, Malak al-Masry, Abdul Jamil Choudhry, Xiaoyan Lu, Dean D. Erdman, Kathleen Tatti, Alison M. Binder, Jessica M. Rudd, Jerome I. Tokars, Congrong Miao, Hussain Alarbash, Randa Nooh, Mark A. Pallansch, Susan I. Gerber, and John T. Watson
Author affiliations: Ministry of Health, Riyadh, Saudi Arabia (A. Assiri, A.A. Bin Saeed, M. al-Masry); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (G.R. Abedi, X. Lu, D.D. Erdman, K. Tatti, A.M. Binder, J. Rudd, J. Tokars, C. Miao, M. Pallansch, S.I. Gerber, J.T. Watson); Taif Governorate Health Directorate, Taif, Saudi Arabia (M.A. Abdalla); Field Epidemiology Training Program, Ministry of Health, Riyadh (A.J. Choudhry, H. Alarbash, R. Nooh)

Main Article

Table 1

Demographic and clinical characteristics of patients with laboratory-confirmed Middle East respiratory syndrome coronavirus infection, Taif, Saudi Arabia, August 2014–February 2015*

Characteristic Patients, n = 38 Survived, n = 17 Died, n = 21 p value
Male sex
 28/38 (74)
 9/17 (53)
 19/21 (90)
 0.023
Nationality
Saudi 22/38 (58) 6/17 (35) 16/21 (76) 0.020
Non-Saudi
 16/38 (42)
 11/17 (65)
 5/21 (24)
Occupation
Healthcare personnel 13/38 (34) 11/17 (65) 2/21 (10) <0.001
Non–healthcare personnel
 25/38 (66)
 6/17 (35)
 19/21 (90)
Underlying medical conditions or behaviors
Renal failure requiring dialysis, n = 36 12/36 (33) 3/16 (19) 9/20 (45) 0.157
Diabetes, n = 34 16/34 (47) 5/16 (31) 11/18 (61) 0.082
Heart disease, n = 30 9/30 (30) 1/14 (7) 8/16 (50) 0.017
Smoker, n = 27 6/27 (22) 1/16 (6) 5/11 (45) 0.027
Any above underlying conditions or behaviors, n = 38
 26/38 (72)
 7/15 (47)
 19/21 (90)
 0.007
Symptoms at onset
Cough, n = 35 27/35 (77) 14/16 (89) 13/19 (68) 0.244
Fever, n = 38 35/38 (92) 15/17 (88) 20/21 (95) 0.577
Shortness of breath, n = 36 21/36 (58) 8/15 (53) 13/21 (62) 0.607
Any respiratory symptoms at onset, n = 38 35/38 (92) 15/17 (88) 21/21 (100) 0.194
Diarrhea, n = 32
 2/32 (6)
 1/15 (7)
 1/17 (6)
 1.000
Clinical course
Pneumonia, n = 36 30/36 (83) 11/17 (65) 19/19 (100) 0.006
Intubation, n = 32 18/32 (56) 3/15 (20) 15/17 (88) <0.001
Intensive care, n = 35
 23/35 (66)
 5/17 (29)
 18/18 (100)
 <0.001
Age, y 51 (17–84) 39 (17–75) 60 (22–84) 0.001
Onset to hospitalization, d 3 (0–10) 4 (0–10) 2 (0–7) 0.060
Onset to death or discharge, d 17 (1–75) 18 (12–42) 14 (1–75) 0.762

*Values are no./total (%) or median (range). Denominators (total number of patients and total numbers of patients who survived and died) vary by characteristic because information was sometimes unavailable in medical charts.

Main Article

Page created: December 18, 2015
Page updated: December 18, 2015
Page reviewed: December 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external